Injury Repair Peptide Stack combining BPC-157 and TB-500 is a dual peptide research formulation supplied in a 2 vial pack. Manufactured for consistent potency, stability, and controlled research applications.
Package Selected: 5 Pack Special
Pay with Interac e-Transfer or Crypto
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
The Injury Repair Peptide Stack supplies BPC-157 and TB-500 as two separate 10mg individually sealed lyophilized vials. One vial of each compound supplied together as a paired research kit. iLab Pharma’s two vial format preserves each peptide’s structural integrity and potency independently until reconstitution, maintaining compound activity across extended research timelines while providing the flexibility to reconstitute each compound separately for protocols requiring individual dose control over each component.
The two separate vial format is a meaningful research distinction from CSD’s pre combined BPC-157 and TB-500 blend formats. The Wolverine Stack 20mg lyophilized vial and Wolverine Pen combine both compounds into a single reconstituted solution, convenient for protocols administering both compounds simultaneously at a fixed ratio. The Injury Repair Peptide Stack’s separate vials allow researchers to reconstitute each compound independently, adjust the administered ratio of BPC-157 to TB-500 based on protocol requirements, administer each compound at different time points within the research schedule, or use one compound while preserving the other for later use; a flexibility that pre combined formats cannot accommodate.
BPC-157 and TB-500’s complementary mechanisms underpin their status as the most extensively co studied peptide pair in tissue repair research. BPC-157 promotes angiogenesis through nitric oxide pathway modulation, upregulates growth hormone receptors in injured tissue, and activates the FAK paxillin pathway driving cell migration and wound healing across tendon, ligament, muscle, gut, and neural tissue research contexts. TB-500 operates through LKKTETQ actin binding domain mediated upregulation of actin polymerization and cell motility. Enhancing cellular migration to injury sites and supporting complementary angiogenic activity through a mechanism distinct from BPC-157’s nitric oxide pathway. The two compounds’ non overlapping mechanisms targeting the same tissue repair outcome make their co administration the most referenced dual peptide protocol in preclinical regenerative biology literature.
iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks BPC-157 and TB-500 across the most comprehensive format range of any peptide combination in our catalogue: this separate 2 vial kit, the Wolverine Stack pre combined vial, the Wolverine Pen, and inclusion across the Glow Pen, GLOW Protocol, KLOW Pen, and KLOW Protocol formats. Giving researchers every co administration format option from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Reconstitute each vial separately with bacteriostatic water prior to use. Store lyophilized vials at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.
Commonly researched in tissue repair, tendon and ligament healing, and regenerative biology research contexts. Browse CSD’s full peptide range for complete sourcing.
